Riskpilot← Back to searchSign inGet full accessCellugy ApS
APSActiveCVR 39463725Maskinvej 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 201821 employeeshttps://www.cellugy.com/
Revenue 2025
DKK -11,1M
+30% vs 2024
EBITDA margin
197.2%
-46% vs 2024
Equity ratio
54.5%
Financial strength
Net profit 2025
DKK -17,2M
-48% vs 2024
| Revenue | DKK -11,1M | +30% |
| EBITDA | DKK -21,8M | -46% |
| Net profit | DKK -17,2M | -48% |
| Total assets | DKK 23,7M | -25% |
| Equity | DKK 12,9M | -57% |
| Employees | 21 | — |
Legal name
Cellugy ApS
CVR number
39463725
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5. april 2018
Share capital
DKK 113.599
Employees
21 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et medlem af bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive udviklingsvirksomhed indenfor biotech og hermed forbundet virksomhed.
Address
Maskinvej 5
Email
info@cellugy.com
Website
https://www.cellugy.com/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 75 | 568 | -94 | 2.160 | 4.047 | -4.094 | -8.532 | -11.057 |
| Staff expenses | -25 | -154 | -572 | -3.452 | -4.823 | -5.730 | -6.414 | -10.743 |
| EBITDA | 50 | 413 | -665 | -1.291 | -776 | -9.824 | -14.946 | -21.799 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 50 | 413 | -665 | -1.291 | -776 | -9.824 | -14.946 | -21.799 |
| Net financials | -0 | -1 | -16 | -71 | -48 | -355 | 344 | 109 |
| Profit before tax | 50 | 412 | -682 | -1.362 | -824 | -10.179 | -14.602 | -21.690 |
| Tax | 11 | 92 | -0 | -300 | -150 | -2.196 | -2.972 | -4.465 |
| Net profit | 39 | 321 | -682 | -1.063 | -674 | -7.983 | -11.629 | -17.225 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 333 | 495 | 1.625 | 4.970 | 2.095 | 7.045 | 31.394 | 23.693 |
| Equity | 42 | 363 | -316 | -1.378 | -2.053 | -131 | 30.131 | 12.907 |
| Long-term debt | 0 | 0 | 1.865 | 0 | 0 | 5.367 | 0 | 0 |
| Short-term debt | 291 | 132 | 76 | 6.348 | 4.147 | 1.810 | 1.262 | 10.786 |
| Total debt | 291 | 132 | 1.941 | 6.348 | 4.147 | 7.177 | 1.262 | 10.786 |
EBITDA margin
-2179925200.0%
This company
15.8%
Market median
-13796995037% vs market
20182025
Equity ratio
54.5%
This company
38.2%
Market median
+43% vs market
20182025
Return on equity
-133.5%
This company
18.4%
Market median
-826% vs market
20182025
Net profit margin
-1722472200.0%
This company
8.1%
Market median
-21265088989% vs market
20182025
Asset turnover
-0.47×
This company
1.12×
Market median
-142% vs market
20182025
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20182025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-04-06 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PS Founder | Founder | 2018 | — | — |
IA Management | Management | 2019 | — | — |
DF Founder | Founder | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
dePais ApS | Company | 33.3% | 33.3% | 2023 |
Danmarks Eksport- og Investeringsfond | Company | 10.0% | 10.0% | 2024 |
The Footprint Fund I K/S | Company | 10.0% | 10.0% | 2024 |
PSV Hafnium Fund I K/S | Company | 10.0% | 10.0% | 2024 |
| Individual | 10.0% | 10.0% | 2024 | |
UV Fund I K/S | Company | 5.0% | 5.0% | 2024 |
| Individual | 5.0% | 5.0% | 2023 | |
FPF North-East HoldCo III ApS | Company | 10.0% | 10.0% | 2023 |
PreSeed Ventures A/S | Company | 10.0% | 10.0% | 2024 |
25Grange Capital Holding ApS | Company | 5.0% | 5.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
dePais ApS
Cellugy ApS Board members of Cellugy ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Paruntungan Sihombing | Founder | 0 companies |
| Isabel Alvarez Martos | Management | 0 companies |
| Deby Fapyane | Founder | 0 companies |
| Andreas Worberg | Board of Directors | 0 companies |
| Pelin Yilmaz | Board of Directors | 0 companies |
| Damien Alan Perriman | Chairman | 0 companies |
| Steven Francis Schnittger | Board of Directors | 0 companies |
| Thomas Bagge Dujardin | Chairman | 0 companies |
| Jonas Ahm-Lundgren | Board of Directors | 0 companies |
| Jakob Rybak-Andersen | Board of Directors | 0 companies |